Heron Therapeutics (HRTX) Operating Margin (2016 - 2026)
Heron Therapeutics (HRTX) operating margin from Dec 31, 2016 to Mar 31, 2026. The current Heron Therapeutics (HRTX) operating margin is -13.71%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Heron Therapeutics (HRTX)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -1.64% | -79.48% |
| 2024 | -7.99% | -90.82% |
| 2023 | -87.07% | -46.33% |
| 2022 | -162.22% | -35.70% |
| 2021 | -252.26% | -2.00% |
| 2020 | -257.40% | +78.33% |
| 2019 | -144.34% | +76.52% |
| 2019 | -81.77% | -42.11% |
| 2019 | -141.24% | -31.02% |
| 2019 | -204.75% | -13.77% |
| 2018 | -237.43% | +12.47% |
| 2018 | -211.12% | -6.10% |
| 2018 | -224.83% | -49.97% |
| 2018 | -449.35% | -28.93% |
| 2017 | -632.30% | +154.17% |
| 2017 | -248.77% | +0.34% |
| 2017 | -247.94% | -70.91% |
| 2017 | -852.34% | -93.62% |
| 2016 | -13352.34% | N/A |
Comparison Heron Therapeutics (HRTX) operating margin with competitors
Heron Therapeutics (HRTX) operating margin is -13.71%.